Deutsch English Français

Contact

EP0680763

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0680763

EP0680763 - Stable preparation for the treatment of blood coagulation disorders comprising an activated coagulation factor and lipid vesicles [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 05.03.2004 Database last updated on 16.11.2024
Most recent event Tooltip	05.03.2004	Application deemed to be withdrawn	published on 21.04.2004 [2004/17]
Applicant(s)	For all designated states Baxter Aktiengesellschaft Industriestrasse 67 1221 Wien / AT
	[1999/50]
Former [1995/45]	For all designated states IMMUNO AG Industriestrasse 67 A-1221 Wien / AT
Inventor(s)	01 / Eibl, Johann, Dr. Gustav Tschermak-G. 2 A-1180 Vienna / AT
	02 / Schwarz, Hans Peter, Doz. Schindlergasse 32 A-1180 Vienna / AT
	03 / Siekmann, Jürgen, Dr. Gerasdorfer Strasse 153/209 A-1210 Vienna / AT
	04 / Turecek, Peter, Dr. Hutweidengasse 41 A-1190 Vienna / AT
	[1995/45]
Representative(s)	Polz, Leo, et al Hoffmann - Eitle ATTENTION : ADDRESS INACTIVE - USE ASS-NR - CDR / DE
	[N/P]
Former [2003/37]	Polz, Leo, Dr., et al Hoffmann Eitle Postfach 81 04 20 81904 München / DE
Former [1995/45]	Kolb, Helga, Dr. Dipl.-Chem., et al Hoffmann, Eitle & Partner, Patent-und Rechtsanwälte, Arabellastrasse 4 D-81925 München / DE
Application number, filing date	95106815.4	05.05.1995
	[1995/45]
Priority number, date	DE19944416180	06.05.1994 Original published format: DE 4416180
	[1995/45]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	EP0680763
	Date:	08.11.1995
	Language:	EN
	[1995/45]
	Type:	A3 Search report
	No.:	EP0680763
	Date:	28.01.1998
	[1998/05]
Search report(s)	(Supplementary) European search report - dispatched on:	EP	11.12.1997
Classification	IPC:	A61K38/48, C12N9/96, // (A61K38/48, 38:36)	[1995/45]
	CPC:	C12N9/96 (EP); A61K38/4846 (EP); A61K38/4866 (EP); A61K9/127 (EP); A61P7/04 (EP); C12N9/647 (EP); (+) C12Y304/21006 (EP); C12Y304/21021 (EP); C12Y304/21069 (EP) (-)
	C-Set:	A61K38/4846, A61K2300/00 (EP); A61K38/4866, A61K2300/00 (EP)
Designated contracting states	AT, BE, CH, DE, DK, ES, FR, GB, IT, LI, NL, SE [1995/45]
Title	German:	Stabile Präparation zur Behandlung von Störungen der Blutgerinnung, die ein aktiviertes Blutgerinnungsfaktor und Lipidvesikeln enthält	[1995/45]
	English:	Stable preparation for the treatment of blood coagulation disorders comprising an activated coagulation factor and lipid vesicles	[1995/45]
	French:	Préparation stable pour le traitement des anomalies de la coagulation du sang comprenant un facteur de coagulation activé et des vésicules lipidiques	[1995/45]
Examination procedure	17.03.1998	Examination requested [1998/20]
	03.06.2003	Despatch of a communication from the examining division (Time limit: M04)
	14.10.2003	Application deemed to be withdrawn, date of legal effect [2004/17]
	18.11.2003	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/17]
Fees paid	Renewal fee
	27.05.1997	Renewal fee patent year 03
	28.05.1998	Renewal fee patent year 04
	25.05.1999	Renewal fee patent year 05
	16.05.2000	Renewal fee patent year 06
	20.04.2001	Renewal fee patent year 07
	21.05.2002	Renewal fee patent year 08
	26.05.2003	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]EP0214737 (UNIV KINGSTON [CA]) [X] 1-4,10,11,13-15,23 * the whole document *;
		[E]EP0680764 (IMMUNO AG [AT]) [E] 1-24 * the whole document *;
		[XP]WO9504524 (OPPERBAS HOLDING BV [NL], et al) [XP] 1-4,10-18,21-24 * figure 1; claims 1-24 * * page 11 *;
		[X]WO9323074 (OKLAHOMA MED RES FOUND [US], et al) [X] 1-4,7,10,11,13-15,23 * the whole document *;
		[X]WO9102532 (UNIV KINGSTON [CA]) [X] 1-4,10,11,14-20 * pages 11-12 *;
		[A]GB2129685 (NAT BIOLOG STANDARDS BOARD) [A] 1-24 * example 26 *;
		[A]US4348384 (HORIKOSHI ISAMU, et al) [A] 1-24 * the whole document *;
		[A]GB2085729 (DAINIPPON PHARMACEUTICAL CO) [A] 1-24 * the whole document *;
		[AD]EP0159311 (IMMUNO AG [AT]) [AD] 16-24 * the whole document *;
		[A]WO9003808 (LIPOSOME CO INC [US]) [A] 1-24 * the whole document *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p